Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Incidence of fractures in people with intellectual disabilities over the life course: a retrospective matched cohort study.

Frighi V. et al, (2022), EClinicalMedicine, 52

Physical health care

Toynbee M. and FRIGHI PEZZELLA V., (2019), Oxford Textbook of Inpatient Psychiatry

Physical health care

FRIGHI PEZZELLA VALERIA. and Toynbee M., (2019), Oxford Textbook of Inpatient Psychiatry

Vitamin D, bone mineral density and risk of fracture in people with intellectual disabilities.

Frighi V. et al, (2018), J Intellect Disabil Res

Vitamin D deficiency in patients with intellectual disabilities: prevalence, risk factors and management strategies.

Frighi V. et al, (2014), Br J Psychiatry, 205, 458 - 464

Safety of antipsychotics in people with intellectual disability.

Frighi V. et al, (2011), Br J Psychiatry, 199, 289 - 295

Exacerbation of pre-existing diabetes by low dose quetiapine.

Frighi V. and Stephenson M., (2010), HbA1c in Diabetes: Case Studies Using IFCC Units

Medical side-effects of antipsychotic agents: hyperprolactinaemia and metabolic disorders

Frighi V., (2010), Therapeutic strategies in schizophrenia, 1 - 19

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.

Baigent C. et al, (2005), Am J Kidney Dis, 45, 473 - 484

Erratum: Effects of three months diet after diagnosis of type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45) (Diabetic Medicine (2000) 17 (518-523))

Holman RR. and Neil HAW., (2001), Diabetic Medicine, 18

Effects of three months' diet after diagnosis of type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45) (vol 17, pg 518, 2000)

Manley SE. et al, (2001), DIABETIC MEDICINE, 18, 251 - 251

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45)

(2000), Diabetic Medicine, 17, 518 - 523

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group.

Manley SE. et al, (2000), Diabet Med, 17, 518 - 523

Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS

Cull C. et al, (1999), DIABETOLOGIA, 42, A18 - A18

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

Turner RC. et al, (1999), JAMA, 281, 2005 - 2012

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49)

(1999), Journal of the American Medical Association, 281, 2005 - 2012

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

Turner RC. et al, (1998), LANCET, 352, 854 - 865

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.

(1998), BMJ, 317, 713 - 720

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

Turner RC. et al, (1998), LANCET, 352, 837 - 853

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

(1998), BMJ, 317, 703 - 713

Load More

Include forthcoming?